Purpose: To compare the de novo incidence of Panayiotopoulos syndrome (PS, early-onset childhood occipital epilepsy) and a common epilepsy syndrome, benign epilepsy with centro-temporal spikes (BECTS), in children and young people. Methods: The incidence of PS and BECTS was recorded over 16 months in a population of children and young people (aged <16 years) living within a specific geographic area and epilepsy network within the North West of England and North Wales and the catchment area of the tertiary paediatric epilepsy centre. Monthly data collection proformas were circulated to the paediatricians and paediatric neurologists responsible for the evaluation of epilepsy in children within this area. This also included monthly reminders of the electro-clinical criteria for these syndromes. EEGs were undertaken in the neurophysiology department of the tertiary paediatric epilepsy centre. The departmental EEG database on all <16 year olds that underwent an EEG during the study period was examined to identify additional patients that may not have been reported via a proforma-reporting system. Results: The incidence of PS and BECTS was found to be 0.8 and 6.1 per 100,000 <16 year olds, respectively. The ages at seizure onset and diagnosis were similar for BECTS and PS. Conclusion: This study is the first to determine a comparative incidence of PS and BECTS. The findings suggest BECTS is eight times more common than PS and that the incidence of PS is lower than previously suggested. Crown
Introduction
Benign epilepsy with centro-temporal spikes (BECTS), now provisionally re-classified by the International League Against Epilepsy (ILAE) as 'pharmaco-sensitive, self-limiting focal epilepsy with centro-temporal spikes', is reported to be the most common focal epilepsy syndrome of childhood. Panayiotopoulos syndrome (PS), also called 'early-onset childhood occipital epilepsy', is a relatively more recently described syndrome. It has been reported to be the second most common epilepsy syndrome after BECTS [1] . A study published over 40 years ago suggested an incidence of BECTS of 21/100,000 children aged 0-15 years [2] and a prevalence of 15-20% of all children with epilepsy [3] . The prevalence of PS is unknown but is considered to affect 13% of children aged 3-6 years and 6% of children aged 1-15 years that have experienced one or more afebrile seizures [4, 5] . It has been suggested that PS may affect up to 2-3 per 1000 (i.e. 200-300 per 100,000) of all children aged <16 years [6] . This figure is unsupported by epidemiological data and has been challenged on the basis of both what seem to be rather loose diagnostic criteria, and from personal experience [4, 7, 8] . A recent population study undertaken in individuals aged one month to 17 years with a new-onset epilepsy over a 24 yearperiod, found an adjusted incidence rate of 44.5 cases per 100,000 per year; two children were diagnosed with PS and 26 children with BECTS [9] .
The aim of this study was to establish the incidence of PS and BECTS within a specific geographical area and large epilepsy network.
Methodology
The definitions of PS and BECTS were based on the ILAE classification [10] and other sources [6, 11] ; the electro-clinical features of which are shown in Table 1 . Patients were included only where they met the clinical and EEG criteria for these syndromes. Gastaut syndrome (GS) together with PS, is classified within the 'benign occipital epilepsies of childhood' (BOEC). Gastaut syndrome may show some clinical features that overlap with PS. More frequent seizures; seizures that predominantly occur during wakefulness; seizures with clearly-described visual symptoms by the child (hallucinations, illusions) and a marked post-ictal headache would favour a diagnosis of GS, rather than PS. Patients were excluded from the study if they showed two or more of these features. Patients were excluded if a structural lesion was identified on brain magnetic resonance imaging (MRI).
The study was undertaken between 1st May 2012 and 31st August 2013 within a geographical area served by a large regional tertiary children's hospital and its eight catchment District General Hospitals (DGHs). All eight DGHs have a children's epilepsy service managed by one or two consultant paediatricians with expertise in epilepsy and a nurse specialist in paediatric epilepsy. This area in the North West of England covers Merseyside and Cheshire and also extends over into North Wales, and comprises a population of approximately 630,000 0-16 year olds [12] .
The study design, data to be recorded and data proformas were agreed by the members of the regional epilepsy network, 'EPilepsy In Children' ('EPIC'). This multi-disciplinary network includes 18 paediatricians with an expertise in epilepsy, three paediatric neurologists with tertiary epilepsy expertise (one of whom is a clinical neurophysiologist in paediatric EEG), 10 epilepsy nurse specialists, one clinical neurophysiologist and five paediatric electrophysiologists (neurology). The data proformas were distributed to all paediatricians and paediatric neurologists within the 'EPIC' network. Monthly e-mail reminders listing the inclusion and exclusion criteria and diagnostic criteria of PS and BECTS and copies of the proformas were circulated to the clinicians and epilepsy nurse specialists in each DGH throughout the studyperiod. Completed proformas were returned to one of the authors (EW) when a patient was diagnosed with PS or BECTS.
All patients resident within the 'EPIC' network catchment area undergo EEG investigations in the paediatric neurophysiology department at the tertiary centre. The electrophysiologists take a focussed seizure history on all patients undergoing an EEG to supplement the history provided on the EEG request form. EEG reports are independently reviewed and reported by the clinical neurophysiologist and one of the paediatric neurologists and author (RA). Patients were only included if the clinical history and EEG findings were consistent with PS or BECTS. Most EEGs are undertaken without prior sleep-deprivation; it is neurophysiology departmental policy to undertake a repeat, sleep-deprived EEG where the initial EEG is equivocal or normal when the clinical history is highly suggestive of a specific syndrome, including PS and BECTS. The EEG database at the tertiary paediatric neurophysiology centre was examined during the study period to identity any cases that might not have been reported via the proforma. Care was taken to not duplicate data. Brain magnetic resonance imaging (MRI) was undertaken on a 1.5T Siemens scanner and all reports were reviewed by the neuroradiologists at the tertiary centre. Brain MRI was considered unnecessary to establish an electro-clinical diagnosis of both PS and BECTS and was therefore not a requirement for inclusion into the study. The decision to perform an MRI scan was left to the discretion and judgement of the clinicians. Children with an abnormal MRI brain scan were excluded even if PS or BECTS was suggested on electro-clinical findings.
Data collected on each patient included; sex, age at seizure onset; seizure type(s) and frequency; age at epilepsy syndrome diagnosis; history of developmental delay or learning problems; EEG findings and results of brain MRI, if undertaken. Patients with an electro-clinical history consistent with a diagnosis of PS or BECTS were entered into the study data-base.
A history of developmental delay or learning difficulties was based on reports of parents/carers, schools and community paediatric services. Children did not undergo standardised assessments of their development or cognitive abilities, Analysis was descriptive.
Results
The study identified 58 patients, 51 with BECTS and seven with PS. All were identified through the data proformas; no patient was identified exclusively from the EEG database. This gives an annual incidence of 0.8 per 100,000 for PS and 6.1 per 100,000 for BECTS in children and young people aged <16 years. Assuming that BECTS accounts for approximately 17.5% (midway between the generally accepted prevalence rates of 15 and 20%) of all epilepsy in children <16 years of age, this would suggest that the annual incidence of epilepsy in this age group in our catchment area is 36 per 100,000. This is similar to previously reported incidence rates of epilepsy of 33.9-46 cases per 100,000 reported in population-based studies [9, [13] [14] [15] [16] .
No patients were considered to have a diagnosis of GS on review of the returned proformas.
Data on the 58 patients are shown in Table 2 . The median age at seizure-onset in PS (7 years 6 months) was similar to BECTS (7 years 7 months) as was the median age at diagnosis (8 years 8 months in PS and 8 years and 11 months in BECTS). Children with PS experienced only focal seizures whilst those with BECTS presented with a mixture of focal and generalised seizures.
Developmental delay or learning difficulties were reported in 33% and 20% of patients with PS and BECTS respectively. All patients of school-age were in mainstream education.
Only one patient, aged four years with PS, had experienced an episode of status epilepticus. This was classified as focal and required admission to the paediatric intensive care unit for 24 h.
Thirteen patients underwent brain magnetic resonance imaging (MRI) prior to diagnosis, one with PS, 12 with BECTS, all with normal findings. No patient with an electro-clinical diagnosis of BECTS or PS had an abnormal brain MRI.
Discussion
Panayiotopoulos syndrome is reported to be one of the more common focal epilepsies of childhood with a prevalence of 6% of all 1-15 year olds with afebrile seizures; this is one third to one half of the reported prevalence of BECTS (15%) [5] . The incidence of PS has not previously been reported. The current study found an incidence of 0.8 per 100,000 which represents the number of new cases of PS seen each year in a population of 100,000 0-16 year olds. The incidence of BECTS at 6.1 per 100,000 was almost eight times higher than that of PS. Our data indicate that PS is a far less common focal epilepsy syndrome than BECTS. This is supported by the population-based study of Wirrell et al. [9] , which demonstrated that BECTS was thirteen times more common than PS (26 patients with BECTS and two with PS). A typical DGH in the UK serves a population of just under 300,000 of which about 60,000 would be aged <16 years. Our data suggest that a child with PS should present to a typically-sized DGH approximately every two years and seven children with BECTS should present in the same period.
The prevalence, and by implication, the incidence of PS may be under-estimated for a number of reasons including a misdiagnosis of "encephalitis, migraine or other non-epileptic paroxysmal disorder" [1] . It is also debatable whether epilepsy should be diagnosed after a single seizure although the ILAE have stated that it is possible to recognise PS after a single seizure episode and therefore this approach was adopted in the present study.
It is unlikely PS was mis-diagnosed as an encephalitis because all children with suspected encephalitis in the study's catchment area are transferred to the tertiary centre for paediatric neurology involvement. It is also unlikely that PS would have been misdiagnosed as a migraine variant or other non-epileptic paroxysmal disorder because of the syndrome's characteristic clinical features and because all paediatricians within the catchment area involved in the care of children with possible epilepsy, including following a first suspected seizure, were cognisant of the syndrome.
It is possible that one or more patients with Gastaut syndrome, the other syndrome classified within the 'benign occipital epilepsies of childhood' (BOEC) may have been wrongly diagnosed as PS in view of some shared clinical and EEG features. However, this is unlikely in view of the distinctive clinical features of GS, including the older age at onset. The incidence of BECTS in this study of 6.1/100,000 was lower than the figure of 21/100,000 reported by Heijbel et al. [2] . However, this latter report was based primarily on children with seizures that were found to have rolandic spikes in their EEG. It is therefore likely to have included patients that did not meet the essential criteria of BECTS as defined by the ILAE. An epilepsy syndrome should only be diagnosed on the basis of clinical features (e.g. age at seizure-onset and seizure-semiology) and EEG findings, and not the EEG alone. Heijbel et al. [2] also accepted they may have over-estimated those with BECTS as they included patients with a single seizure. Finally, they acknowledged their observed incidence rates for all types of epilepsy in childhood and adolescence was twice that of an earlier population study [15] . The current study used strict electroclinical criteria and consequently, it is likely that the lower incidence of BECTS is the more accurate.
A small proportion of patients with both PS and BECTS underwent brain MRI. Guidance from the National Institute for Health and Care Excellence (NICE) in the UK advise that brain MRI is not indicated in patients with BECTS but there is no similar guidance for PS [17] . Yalcin et al. [1] considered that abnormal brain MRI in PS may be coincidental or represent "atypical" forms and does not preclude its diagnosis; this risks reducing or even negating the value of the defining criteria of any epilepsy syndrome, including PS. In contrast, it is likely that for most clinicians, an abnormal MRI brain scan would tend to preclude a diagnosis of BECTS; the same is likely to also apply to PS.
This study has a number of potential limitations. First, it was undertaken for only 16 months and it is possible that a longer period would have provided more robust data. However, we consider it unlikely that a longer study comprising of a larger population would have yielded significantly different results and specifically in both the absolute and relative incidences of the two syndromes.
To our knowledge, this is the first study to report the incidence of PS and a comparative study of both PS and BECTS. The data are consistent with other and broader epidemiological data. Second, it is possible that ascertainment may have been incomplete because patients may have experienced a single seizure and did not undergo an EEG; however, this would apply equally to BECTS, preserving their relative incidence in the study. Furthermore, all children with epilepsy and a single seizure were assessed by clinicians with an expertise in epilepsy and members of a large epilepsy network. In addition, all children under 16 years of age undergo EEG investigations in one paediatric neurophysiology department and its EEG database was examined to identify additional patients not reported via the study proformas. Consequently, it is unlikely that there was a significant underdiagnosis of either syndrome and particularly PS.
Conclusion
This study found an incidence of PS syndrome of 0.8, and of BECTS of 6.1, per 100,000 persons <16 years of age, indicating it occurs eight times less frequently than BECTS. This suggests that PS is not as common as previous reports have claimed, even if one accepts that an epilepsy syndrome can be recognised after a single seizure. Both epilepsy syndromes demonstrated a similar age of seizure onset and diagnosis.
